IL96747A0 - Oxazole derivatives and pharmaceutical compositions containing them - Google Patents

Oxazole derivatives and pharmaceutical compositions containing them

Info

Publication number
IL96747A0
IL96747A0 IL96747A IL9674790A IL96747A0 IL 96747 A0 IL96747 A0 IL 96747A0 IL 96747 A IL96747 A IL 96747A IL 9674790 A IL9674790 A IL 9674790A IL 96747 A0 IL96747 A0 IL 96747A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
oxazole derivatives
oxazole
derivatives
Prior art date
Application number
IL96747A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of IL96747A0 publication Critical patent/IL96747A0/xx
Priority to IL11240895A priority Critical patent/IL112408A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/46Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL96747A 1989-12-20 1990-12-20 Oxazole derivatives and pharmaceutical compositions containing them IL96747A0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IL11240895A IL112408A0 (en) 1989-12-20 1995-01-20 Oxazole derivatives and pharmaceutical compositions containing them

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45354889A 1989-12-20 1989-12-20
US58002190A 1990-09-10 1990-09-10

Publications (1)

Publication Number Publication Date
IL96747A0 true IL96747A0 (en) 1991-09-16

Family

ID=27037150

Family Applications (1)

Application Number Title Priority Date Filing Date
IL96747A IL96747A0 (en) 1989-12-20 1990-12-20 Oxazole derivatives and pharmaceutical compositions containing them

Country Status (12)

Country Link
EP (1) EP0434034A1 (xx)
JP (1) JPH04217966A (xx)
KR (1) KR910011810A (xx)
CN (4) CN1028173C (xx)
CA (1) CA2032674A1 (xx)
FI (1) FI906213A (xx)
HU (2) HU206100B (xx)
IL (1) IL96747A0 (xx)
NO (1) NO905444L (xx)
NZ (1) NZ236474A (xx)
PT (1) PT96276A (xx)
YU (1) YU240990A (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5254576A (en) * 1992-04-03 1993-10-19 Bristol-Myers Squibb Company Diphenyl-heterocyclic-oxazole as platelet aggregation inhibitors
US5187188A (en) * 1992-04-03 1993-02-16 Bristol-Myers Squibb Company Oxazole carboxylic acid derivatives
US5348969A (en) * 1992-04-03 1994-09-20 Bristol-Myers Squibb Company Diphenyloxazolyl-oxazoles as platelet aggregation inhibitors
US5362879A (en) * 1993-04-15 1994-11-08 Bristol-Myers Squibb Company 4-5-diphenyloxazole derivatives as inhibitors of blood platelet aggregation
DE4330959A1 (de) * 1993-09-09 1995-03-16 Schering Ag Neue Benzimidazolderivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
CA2179399A1 (en) * 1993-12-20 1995-06-29 Kiyoshi Taniguchi 4,5-diaryloxazole derivatives
TW401408B (en) * 1995-07-21 2000-08-11 Fujisawa Pharmaceutical Co Heterocyclic compounds having prostaglandin I2 agonism
DE69941777D1 (de) * 1998-03-10 2010-01-21 Ono Pharmaceutical Co Carbonsäurederivate und medikamente die diese als aktiven wirkstoff enthalten
PE20060362A1 (es) * 2004-05-24 2006-05-15 Irm Llc Compuestos de oxazol como moduladores de ppar
RU2008122547A (ru) * 2005-11-07 2009-12-20 Айрм Ллк (Bm) Соединения и композиции как модуляторы арпп (активированных рецепторов пролифератора пероксисом)
EP2816023A4 (en) 2012-02-13 2015-09-09 Takeda Pharmaceutical AROMATIC CORE COMPOUND
EP2816032A4 (en) 2012-02-13 2015-09-30 Takeda Pharmaceutical AROMATIC CORE COMPOUND

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1206403A (en) * 1966-12-15 1970-09-23 Wyeth John & Brother Ltd Oxazoles
US3578671A (en) * 1967-11-06 1971-05-11 Wyeth John & Brother Ltd Oxazoles
DE2129012A1 (de) * 1971-06-11 1973-01-04 Merck Patent Gmbh Azol-derivate
US3895115A (en) * 1974-03-01 1975-07-15 Serono Ist Farm Method of inhibiting platelet aggregation
GB1507032A (en) * 1974-08-06 1978-04-12 Serono Lab 2-thiol-4,5-diphenyloxazole s-derivatives

Also Published As

Publication number Publication date
HU908361D0 (en) 1991-07-29
CN1028173C (zh) 1995-04-12
EP0434034A1 (en) 1991-06-26
HU206100B (en) 1992-08-28
CN1101042A (zh) 1995-04-05
CN1052667A (zh) 1991-07-03
NO905444L (no) 1991-06-21
NZ236474A (en) 1993-07-27
NO905444D0 (no) 1990-12-18
JPH04217966A (ja) 1992-08-07
HU9201706D0 (en) 1992-08-28
HUT59116A (en) 1992-04-28
FI906213A0 (fi) 1990-12-17
KR910011810A (ko) 1991-08-07
YU240990A (sh) 1992-12-21
CN1101043A (zh) 1995-04-05
CN1101041A (zh) 1995-04-05
FI906213A (fi) 1991-06-21
CA2032674A1 (en) 1991-06-21
PT96276A (pt) 1991-09-30

Similar Documents

Publication Publication Date Title
NZ233320A (en) 3-substituted-2-oxo-indole derivatives and pharmaceutical compositions
IL95351A0 (en) 17beta-acyl-4-aza-5alpha-androst-1-en-3-ones and pharmaceutical compositions containing them
IL90067A0 (en) 1alpha-hydroxyvitamin-d compounds and pharmaceutical compositions containing them
IL88988A0 (en) Didehydro-vitamin d3 derivatives and pharmaceutical compositions containing them
NZ220345A (en) Imidazoquinolinylether derivatives and pharmaceutical compositions containing them
NZ220880A (en) Di-tert-butyl-phenol derivatives and pharmaceutical compositions
NZ225398A (en) Oxadiazole derivatives and pharmaceutical compositions
PH27603A (en) Phenol substituted gemdiphosphonate derivatives and pharmaceutical compositions containing them
NZ221996A (en) Imidazo-pyridine derivatives and pharmaceutical compositions
NZ220171A (en) Dihydro-benzopyran derivatives and pharmaceutical compositions
NZ233790A (en) Benzocycloalkane derivatives and pharmaceutical compositions
NZ233011A (en) Thieno-triazole-diazepine and pharmaceutical compositions
HU896612D0 (en) Process for the preparation of 2-iminebenzothiazole derivatives and pharmaceutical compositions thereof
HU896479D0 (en) Process for the preparation of capsaycin derivatives and pharmaceutical compositions thereof
IL96747A0 (en) Oxazole derivatives and pharmaceutical compositions containing them
NZ236483A (en) Glycerol derivatives and pharmaceutical compositions thereof
NZ228812A (en) Quinolazine derivatives; pharmaceutical compositions and preparatory processes
NZ217871A (en) Oxazole derivatives and pharmaceutical compositions
NZ234174A (en) Dihydroindenoindole derivatives and compositions containing them
NZ232701A (en) Substituted benzoxazolinone derivatives and pharmaceutical compositions
NZ225613A (en) Benzazepin-2-one derivatives and pharmaceutical compositions
NZ233013A (en) Substituted thieno-triazolo-diazepine derivatives and pharmaceutical compositions
IL89155A0 (en) Ouabain-like compounds and pharmaceutical compositions containing them
NZ223051A (en) Carbamoyloxylabdane derivatives and pharmaceutical compositions
KR960009424B1 (en) Rhodanine derivatives and pharmaceutical compositions